Literature DB >> 19691111

Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.

Jordi Camps1, Quang Tri Nguyen, Hesed M Padilla-Nash, Turid Knutsen, Nicole E McNeil, Danny Wangsa, Amanda B Hummon, Marian Grade, Thomas Ried, Michael J Difilippantonio.   

Abstract

To evaluate the mechanisms and consequences of chromosomal aberrations in colorectal cancer (CRC), we used a combination of spectral karyotyping, array comparative genomic hybridization (aCGH), and array-based global gene expression profiling on 31 primary carcinomas and 15 established cell lines. Importantly, aCGH showed that the genomic profiles of primary tumors are recapitulated in the cell lines. We revealed a preponderance of chromosome breakpoints at sites of copy number variants (CNVs) in the CRC cell lines, a novel mechanism of DNA breakage in cancer. The integration of gene expression and aCGH led to the identification of 157 genes localized within high-level copy number changes whose transcriptional deregulation was significantly affected across all of the samples, thereby suggesting that these genes play a functional role in CRC. Genomic amplification at 8q24 was the most recurrent event and led to the overexpression of MYC and FAM84B. Copy number dependent gene expression resulted in deregulation of known cancer genes such as APC, FGFR2, and ERBB2. The identification of only 36 genes whose localization near a breakpoint could account for their observed deregulated expression demonstrates that the major mechanism for transcriptional deregulation in CRC is genomic copy number changes resulting from chromosomal aberrations. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691111      PMCID: PMC4721599          DOI: 10.1002/gcc.20699

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  42 in total

1.  Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations.

Authors:  B M Ghadimi; D L Sackett; M J Difilippantonio; E Schröck; T Neumann; A Jauho; G Auer; T Ried
Journal:  Genes Chromosomes Cancer       Date:  2000-02       Impact factor: 5.006

2.  Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection.

Authors:  X Y Guan; P S Meltzer; W S Dalton; J M Trent
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

3.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

4.  Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53.

Authors:  J R Eshleman; G Casey; M E Kochera; W D Sedwick; S E Swinler; M L Veigl; J K Willson; S Schwartz; S D Markowitz
Journal:  Oncogene       Date:  1998-08-13       Impact factor: 9.867

5.  Characterization of a cryptic 3.3 Mb deletion in a patient with a "balanced t(15;22) translocation" using high density oligo array CGH and gene expression arrays.

Authors:  Marilyn M Li; Manjunath A Nimmakayalu; Danielle Mercer; Hans C Andersson; Beverly S Emanuel
Journal:  Am J Med Genet A       Date:  2008-02-01       Impact factor: 2.802

6.  Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

Authors:  Sílvia Beà; Itziar Salaverria; Lluís Armengol; Magda Pinyol; Verónica Fernández; Elena M Hartmann; Pedro Jares; Virginia Amador; Luís Hernández; Alba Navarro; German Ott; Andreas Rosenwald; Xavier Estivill; Elias Campo
Journal:  Blood       Date:  2008-11-04       Impact factor: 22.113

7.  Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.

Authors:  Eric S Martin; Giovanni Tonon; Raktim Sinha; Yonghong Xiao; Bin Feng; Alec C Kimmelman; Alexei Protopopov; Elena Ivanova; Cameron Brennan; Kate Montgomery; Raju Kucherlapati; Gerald Bailey; Mark Redston; Lynda Chin; Ronald A DePinho
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Negative implication of C-MYC as an amplification target in esophageal cancer.

Authors:  Xiao-Ping Huang; Tie-Hua Rong; Jun-Ye Wang; Ya-Qiong Tang; Bao-Jiang Li; Duo-Rong Xu; Mei-Qing Zhao; Lan-Jun Zhang; Yan Fang; Xiao-Dong Su; Qi-Wan Liang
Journal:  Cancer Genet Cytogenet       Date:  2006-02

Review 9.  The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Authors:  Aleix Prat; José Baselga
Journal:  Nat Clin Pract Oncol       Date:  2008-07-08

10.  Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.

Authors:  J A Squire; P S Thorner; S Weitzman; J D Maggi; P Dirks; J Doyle; M Hale; R Godbout
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

View more
  48 in total

1.  Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances.

Authors:  Hesed M Padilla-Nash; Karen Hathcock; Nicole E McNeil; David Mack; Daniel Hoeppner; Rea Ravin; Turid Knutsen; Raluca Yonescu; Danny Wangsa; Kathleen Dorritie; Linda Barenboim; Yue Hu; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2011-12-08       Impact factor: 5.006

Review 2.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

3.  Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment.

Authors:  Julieta Aprea; Silvia Prenninger; Martina Dori; Tanay Ghosh; Laura Sebastian Monasor; Elke Wessendorf; Sara Zocher; Simone Massalini; Dimitra Alexopoulou; Mathias Lesche; Andreas Dahl; Matthias Groszer; Michael Hiller; Federico Calegari
Journal:  EMBO J       Date:  2013-11-15       Impact factor: 11.598

4.  A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.

Authors:  Marian Grade; Amanda B Hummon; Jordi Camps; Georg Emons; Melanie Spitzner; Jochen Gaedcke; Patrick Hoermann; Reinhard Ebner; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Tim Beissbarth; Natasha J Caplen; Thomas Ried
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

5.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 6.  The consequences of chromosomal aneuploidy on the transcriptome of cancer cells.

Authors:  Thomas Ried; Yue Hu; Michael J Difilippantonio; B Michael Ghadimi; Marian Grade; Jordi Camps
Journal:  Biochim Biophys Acta       Date:  2012-03-06

7.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

8.  Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas.

Authors:  Nicole E McNeil; Hesed M Padilla-Nash; Floryne O Buishand; Yue Hue; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2016-11-01       Impact factor: 5.006

9.  IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.

Authors:  Yongzhong Wu; Mariam M Konaté; Jiamo Lu; Hala Makhlouf; Rodrigo Chuaqui; Smitha Antony; Jennifer L Meitzler; Michael J Difilippantonio; Han Liu; Agnes Juhasz; Guojian Jiang; Iris Dahan; Krishnendu Roy; James H Doroshow
Journal:  J Immunol       Date:  2019-09-23       Impact factor: 5.422

10.  Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

Authors:  José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.